TMC-310911
| CAS号 | 1000287-05-7 | 货号 | BCP44275 |
| 中文名 | TMC-310911 | ||
| 英文名 | TMC-310911 | ||
| 中文别名 | |||
| 英文别名 | ASC-09; TMC310911; ASC09; TMC 310911; ASC 09; | ||
| 分子式 | C38H53N5O7S2 | 分子量 | 755.99 |
| 生物活性 | TMC-310911 is a novel investigational protease inhibitor (PI) that is structurally similar to the currently available [darunavir]. It is being investigated for use in HIV-1 infections. TMC-310911 has shown marked activity against a variety of HIV-1 strains, including multi-PI-resistant strains, and may be less likely to generate resistance, making it a potentially desirable therapy for both treatment-naive and PI-experienced patients. TMC-310911 is currently being investigated, in combination with other HIV therapies and antivirals, as a potential treatment for COVID-19 caused by SARS-CoV-2. | ||
| 信号通路 | Protease/Metabolic Enzyme | ||
| 靶 点 | HIV Protease | ||
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服：
- 全国免费电话：400-099-8200
- 在线客服:
瀚香生物（Biochempartner) 的所有产品和服务仅用于科学研究，禁止用于人体和治疗！